Therefore, in view of the putative role of irisin in prevention, control and therapy of numerous metabolic disorders [11,12] implied in HF, we aimed to evaluate the circulating irisin levels in HFrEF and HFpEF patients and correlate them with several metabolic and oxidative parameters. The gene discussed is FNDC5; the disease is metabolic disease.